References
- Firth JW, Stevens PM, Brownsill RD, Lopez N, Walls CM, Vose CW. 1990. Metabolism of the imidazole group in an anti-infective trichlorophenylhydrazone derivative. Methodol Surr Biochem Anal 20:211–214.
- Fujita S, Chiba M, Ohta M, Kitani K, Suzuki T. 1990. Alteration of plasma sex hormone levels associated with old age and its effect on hepatic drug metabolism in rats. The Journal of Pharmacology and Experimental Therapeutics 253:369–374.
- Fukunaga K, Ohmitsu M, Miyamoto E, Sato T, Sugimura M, Uchida T, Shirasaki Y. 2000. Inhibition of neuronal nitric oxide synthase activity by 31214-(3-chloro-2-methylpheny1)-1-piperazinyl]ethy1]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3. 5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ. Biochemical Pharmacology 60:693–699.
- Girkin R, Brodie RR, Midgley I, Hawkins DR, Chasseaud LF. 1983. Comparison of the plasma and urinary metabolites of [3H] -econazole nitrate in the monkey and pregnant and non-pregnant rat. Eur J Drug Metab Pharmacokin 8:109–116.
- Hashiguchi A, Kawano T, Yano S, Morioka M, Hamada J, Sato T, Shirasaki Y, Ushio Y, Fukunaga K. 2003. The neuroprotective effect of a novel calmodulin antagonist, 31214-(3-chloro-2-methylpheny1)-1-piperaziny1]-ethyl] -5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, in transient forebrain ischemia. Neuroscience 121:379–386.
- Iwata H, Fujita K, Kushida H, Suzuki A, Konno Y, Nakamura K, Fujin° A, Kamataki T. 1998. High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochemical Pharmacology 55:1315–1325.
- Midgley I, Van Bladeren PJ, Hawkins DR, Chasseaud LF, Darragh A, Brodie RR, Walmsley LM. 1981. The metabolic fate of [3H]econazole in man. Xenobiotica 11:595–608.
- Nakano M, Nakajima Y, Iwatani K, Ikenishi Y, Nakagawa Y, Sugeno K. 1989. Metabolism of the antimycotic agent, croconazole, in rabbits. Drug Metabolism and Disposition: The Biological Fate of Chemicals 17:323–329.
- Nakaoka M, Hakusui H. 1987. Identification of the metabolites of a new hypoglycaemic agent, midaglizole, in dogs. Xenobiotica 17:1329–1339.
- Rush WR, Alexander OF, Hall DJ, Dow RJ, Tokes L, Kurz L, Graham DJ. 1990. The metabolism of nafunidone hydrochloride in the dog, primates and man. Xenobiotica 20:123–132.
- Sato T, Morishima Y, Shirasaki Y. 2003. 31214-(3-chloro-2-methylpheny1)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3. 5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia. The Journal of Pharmacology and Experimental Therapeutics 304:1042–1047.
- Sato T, Morishima Y, Sugimura M, Uchida T, Shirasaki Y. 1999. DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia. European Journal of Pharmacology 370:117–123.
- Sato T, Takamori H, Shirasaki Y. 2004. DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats. Pharmacology 71:38–45.
- Sugimura M, Sato T, Nakayama W, Morishima Y, Fukunaga K, Omitsu M, Miyarnoto E, Shirasaki Y. 1997. DY-9760e, a novel calmodulin antagonist with cytoprotective action. European Journal of Pharmacology 336:99–106.
- Tachibana S, Fujimaki Y, Tachibana M, Tanaka M, Kurata T, Okazaki O, Sudo K. 2005. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys. Armeimittel Forschung/Drug Res 3:135–144.
- Tachibana S, Tanaka M, Fujimaki Y, Ookuma T, Ohori Y, Hayashi K, Iwata H, Sudo K. 2001. In vitro metabolism of DY-9760e, a novel calmodulin antagonis, by human, monkey, dog, rat liver microsomes. Paper presented at the 6th International Meeting of International Society for the Study of Xenobiotics, 7–11 October, Munich, Germany.
- Takagi K, Sato T, Shirasaki Y, Narita K, Tamura A, Sano K. 2001. Post-ischemic administration of DY-9760e, a novel calmodulin antagonist, reduced infarct volume in the permanent focal ischemia model of spontaneously hypertensive rat. Neurological Research 23:662–668.
- Whitehouse LW, Menzies A, Dawson B, Cyr TD, By AW, Black DB, Zarnecnik J. 1994. Mouse hepatic metabolites of ketoconazole; isolation and structure elucidation. Journal of Pharmaceutical and Biomedical Analysis 12:1425–1441.